SCHEMBL24316556

SCHEMBL24316556

CCOc1cc(Oc2ccc3ncc(C)c(=O)n3c2)cnc1O

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 4/20 0.41
GLA P06280 3/20 0.41
GAA P10253 3/20 0.41
PRMT5 O14744 1/20 0.34
WDR77 Q9BQA1 1/20 0.34
MAPT P10636 1/20 0.34
ALDH1A1 P00352 3/20 0.33
HPGD P15428 2/20 0.33
POLB P06746 1/20 0.33
NPC1 O15118 1/20 0.33
TP53 P04637 1/20 0.33
CYP1A2 P05177 1/20 0.33
CYP2C19 P33261 1/20 0.33
RAB9A P51151 1/20 0.33
HSD17B10 Q99714 1/20 0.33
DGAT2 Q96PD7 1/20 0.33
NPBWR1 P48145 2/20 0.33
RXFP1 Q9HBX9 1/20 0.32
THRB P10828 1/20 0.32
PIK3CA P42336 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29539198 1.00 KDM4E (0.41) KDM4EGLAGAAPRMT5WDR77
SCHEMBL24316804 0.90 KDM4E (0.35) KDM4EGLAGAAALDH1A1HPGD
SCHEMBL24316808 0.89 POLB (0.41) KDM4EGLAGAAPRMT5WDR77
SCHEMBL24316797 0.87 KDM4E (0.38) KDM4EGLAGAAPRMT5WDR77
SCHEMBL24316426 0.77 CSF1R (0.46) KDM4EGLAGAADGAT2MCHR1
SCHEMBL24316434 0.74 CSF1R (0.53) KDM4EALDH1A1HPGDPOLBNPC1
SCHEMBL24316624 0.74 KDM4E (0.36) KDM4EGLAGAAALDH1A1HPGD
SCHEMBL24316983 0.74 CSF1R (0.46) ALDH1A1RXFP1PIK3CAMTORGRM5
SCHEMBL24316982 0.74 CSF1R (0.48) KDM4EGLAGAAALDH1A1HPGD
SCHEMBL24316436 0.70 KDM4E (0.37) KDM4EGLAGAAALDH1A1POLB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20240092774-A1 HETEROAROMATIC COMPOUNDS AND USES THEREOF HUTCHISON MEDIPHARMA LIMITED (CN) 2024-03-21 US disclosed
WO-2022057895-A1 HETEROAROMATIC COMPOUNDS AND USES THEREOF HUTCHISON MEDIPHARMA LIMITED (CN) 2022-03-24 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20240092774-A1 HETEROAROMATIC COMPOUNDS AND USES THEREOF CYP2D6, CYP3A7, CYP2F1 KDM4E 4085/4885GLA 1120/4885GAA 323/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.